HomeMedical Oncology

Medical Oncology

Physician insights on cancer treatment protocols, immunotherapy, targeted therapies, and clinical trial updates.

Recent Discussions

How do you choose bridging therapy prior to CAR-T leukapheresis?

1 Answers

Mednet Member

Medical Oncology · Rutgers Cancer Institute of New Jersey

There is a lack of uniform clarity around terminology here. To avoid confusion, I prefer using "debulking" for treatment that is administered prior to T-cell apheresis, and "bridging" for treatment administered after apheresis to bridge the patient during manufacture to maintain disease control prio...

Do you use GCSF for a patient with MDS with excess blasts and neutropenia?

1 Answers

Mednet Member

Medical Oncology · Riverside Methodist Hospitals/OhioHealth

It really depends on what you are trying to achieve: If the goal is to get the patient to a curative allogeneic transplant, then the answer is no. If the goal is to get an elderly frail patient to break fever and leave the hospital to spend some quality time with family, then the answer is yes!

Medical Oncology

Recent Discussions

How do you choose bridging therapy prior to CAR-T leukapheresis?

Do you use GCSF for a patient with MDS with excess blasts and neutropenia?

Noelle K. LoConte, MD

Stephen V. Liu, MD

Sara M. Tolaney, MD, MPH

Lawrence H. Einhorn, MD

John C. Byrd, MD

Anthony Bejjani

Elizabeth Henry

John Baird